Skip to main content

Table 4 Proposal for drug coding of “List of drugs to consider starting” 1)

From: Identifying drug substances of screening tool for older persons’ appropriate prescriptions for Japanese

Therapeutic category/JAN English name

Japan 2)

ATC 2)

Antiparkinson drugs

 Combination (see Table 5)

  

Vaccine: Influenza

 Influenza HA Vaccine (A/B)

NA

J07BB02

 Adsorbed Influenza Virus Vaccine (H5N1)

NA

J07BB02

Vaccine: Pneumococcal

 Pneumococcal Polysaccharide Conjugate Vaccine(adsorbed)

631140G

J07AL52

 Pneumococcus Vaccine

6311400

J07AL01

Cardiovascular system: Angiotensin conversion enzyme (ACE) inhibitor

 Alacepril

2144003

C09AA

 Benazepril Hydrochloride

2144007

C09AA07

 Captopril

2144001

C09AA01

 Cilazapril Hydrate

2144005

C09AA08

 Delapril Hydrochloride

2144004

C09AA12

 Enalapril Maleate

2144002

C09AA02

 Imidapril Hydrochloride

2144008

C09AA16

 Lisinopril Hydrate

2144006

C09AA03

 Perindopril Erbumine

2144012

C09AA04

 Quinapril Hydrochloride

2144010

C09AA06

 Temocapril Hydrochloride

2144009

C09AA14

 Trandolapril

2144011

C09AA10

Cardiovascular system: Angiotensin receptor blocker (ARB)

 Azilsartan

2149048

C09CA09

 Candesartan Cilexetil

2149040

C09CA06

 Irbesartan

2149046

C09CA04

 Olmesartan Medoxomil

2149044

C09CA08

 Telmisartan

2149042

C09CA07

 Valsartan

2149041

C09CA03

 Losartan Potassium

2149039

C09CA01

 Coombination (See Table 5)

  

Cardiovascular system: Lipid modifying agents (Statine)

 Atorvastatin Calcium Hydrate

2189015

C10AA05

 Fluvastatin Sodium

2189012

C10AA04

 Pitavastatin Calcium Hydrate

2189016

C10AA08

 Pravastatin Sodium

2189010

C10AA03

 Rosuvastatin Calcium

2189017

C10AA07

 Simvastatin

2189011

C10AA01

 Coombination (See Table 5)

  

Urologicals: Drugs for benign prostatic hypertrophy (selective alpha-1 blockers)

 Naftopidil

2590009

G04CA

 Silodosin

2590010

G04CA04

 Tamsulosin Hydrochloride

2590008

G04CA02

Antineoplastic and immunomodulating agents: Drugs for rheumatoid arthritis

 Actarit

1149031

M01CX

 Auranofin

4420001

M01CB03

 Bucillamine

4420002

M01CC02

 Iguratimod

3999031

M01CX

 Leflunomide

3999020

L04AA13

 Lobenzarit Sodium

1149020

M01CX

Methotrexate

4222001

3999016

L01BA01

L04AX03

 Mizoribine

3999002

L04AX

 Salazosulfapyridine

6219001

A07EC01

 Tofacitinib Citrate

3999034

L04AA29

  1. ATC: Anatomical Therapeutic Chemical Classification System
  2. JAN: Japanese Accepted Names for Pharmaceuticals
  3. 1)Drugs that had been previously approved but do not currently being marketed are excluded. The list includes long-term oral use drugs as a general rule, except self-injection insulin, according to the guidelines (Japan Geriatric Society. Guidelines for Medical Treatment and its Safety in the elderly 2015 (In Japanese). Toyko, Medical View Co., Ltd. 2015.)
  4. 2)the first 7-digit numbers of the code of the Japanese drug price list.A different base adduct may or may not require different codes in Japan; hydroxyzine (1179005 for hydrochloride, 1179019 for pamoate) or promethazines (4413002).
  5. 3)ATC codes for topical use were excluded, e.g. A07EA Corticosteroids acting locally, D04AA Antihistamines for topical use; defined daily dose (DDD) are not available for most of those.